Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - US2582781009 - Common Stock

164.99 USD
+1.32 (+0.81%)
Last: 9/8/2025, 12:17:25 PM
Fundamental Rating

7

Taking everything into account, DORM scores 7 out of 10 in our fundamental rating. DORM was compared to 80 industry peers in the Automobile Components industry. DORM gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, DORM is valued expensive at the moment. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
DORM had positive earnings in each of the past 5 years.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of DORM (9.14%) is better than 96.25% of its industry peers.
The Return On Equity of DORM (16.14%) is better than 93.75% of its industry peers.
DORM has a Return On Invested Capital of 12.70%. This is amongst the best in the industry. DORM outperforms 93.75% of its industry peers.
DORM had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 8.51%.
The last Return On Invested Capital (12.70%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROIC 12.7%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM has a better Profit Margin (10.83%) than 97.50% of its industry peers.
In the last couple of years the Profit Margin of DORM has grown nicely.
DORM has a Operating Margin of 15.75%. This is amongst the best in the industry. DORM outperforms 98.75% of its industry peers.
DORM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 40.88%, DORM belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
The number of shares outstanding for DORM has been reduced compared to 1 year ago.
DORM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 5.27 indicates that DORM is not in any danger for bankruptcy at the moment.
The Altman-Z score of DORM (5.27) is better than 86.25% of its industry peers.
DORM has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as DORM would need 3.31 years to pay back of all of its debts.
DORM's Debt to FCF ratio of 3.31 is amongst the best of the industry. DORM outperforms 91.25% of its industry peers.
DORM has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, DORM belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Altman-Z 5.27
ROIC/WACC1.33
WACC9.55%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.74. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
DORM has a Current ratio of 2.74. This is amongst the best in the industry. DORM outperforms 85.00% of its industry peers.
DORM has a Quick Ratio of 1.21. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.21, DORM is doing good in the industry, outperforming 71.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 1.21
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.49%, which is quite impressive.
The Earnings Per Share has been growing by 21.83% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 6.76% in the past year.
The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%

3.2 Future

Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 6.18% on average per year.
EPS Next Y21.23%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5Y7.8%
Revenue Next Year8.63%
Revenue Next 2Y6.14%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.02, DORM is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of DORM is on the same level as its industry peers.
DORM is valuated rather cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 18.24, DORM is valued on the expensive side.
Based on the Price/Forward Earnings ratio, DORM is valued a bit more expensive than the industry average as 63.75% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of DORM to the average of the S&P500 Index (22.66), we can say DORM is valued inline with the index average.
Industry RankSector Rank
PE 20.02
Fwd PE 18.24
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than the industry average as 71.25% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, DORM is valued a bit more expensive than 63.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.15
EV/EBITDA 14.14
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DORM has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DORM's earnings are expected to grow with 12.56% in the coming years.
PEG (NY)0.94
PEG (5Y)0.92
EPS Next 2Y12.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (9/8/2025, 12:17:25 PM)

164.99

+1.32 (+0.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners86.17%
Inst Owner Change1.82%
Ins Owners10.8%
Ins Owner Change0.28%
Market Cap5.04B
Analysts81.67
Price Target166.6 (0.98%)
Short Float %3.51%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.85%
Min EPS beat(2)11.58%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)20.79%
Min EPS beat(4)9.67%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)21.58%
EPS beat(12)7
Avg EPS beat(12)9.41%
EPS beat(16)8
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.34%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)0.63%
PT rev (1m)12.06%
PT rev (3m)12.06%
EPS NQ rev (1m)34.58%
EPS NQ rev (3m)25.52%
EPS NY rev (1m)8.73%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)5.44%
Revenue NQ rev (3m)4.09%
Revenue NY rev (1m)3.7%
Revenue NY rev (3m)3.7%
Valuation
Industry RankSector Rank
PE 20.02
Fwd PE 18.24
P/S 2.41
P/FCF 36.15
P/OCF 28.7
P/B 3.6
P/tB 7.33
EV/EBITDA 14.14
EPS(TTM)8.24
EY4.99%
EPS(NY)9.05
Fwd EY5.48%
FCF(TTM)4.56
FCFY2.77%
OCF(TTM)5.75
OCFY3.48%
SpS68.33
BVpS45.85
TBVpS22.52
PEG (NY)0.94
PEG (5Y)0.92
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROCE 16.84%
ROIC 12.7%
ROICexc 13.08%
ROICexgc 20.96%
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
FCFM 6.68%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Debt/EBITDA 1.12
Cap/Depr 64.28%
Cap/Sales 1.73%
Interest Coverage 10.99
Cash Conversion 45.61%
Profit Quality 61.66%
Current Ratio 2.74
Quick Ratio 1.21
Altman-Z 5.27
F-Score7
WACC9.55%
ROIC/WACC1.33
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
EPS Next Y21.23%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5Y7.8%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%
Revenue Next Year8.63%
Revenue Next 2Y6.14%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%
EBIT growth 1Y22.22%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year26.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.44%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y80.56%
OCF growth 3Y32.07%
OCF growth 5Y19.38%